Novo Nordisk to address social inequality in dialogue with healthcare systems -CEO
COPENHAGEN (Reuters) – Novo Nordisk CEO Lars Fruergaard Jorgensen said on Friday the company will work with European government healthcare systems to ensure less fortunate and the most obese people get access to its Wegovy weight-loss drug. “In Europe, we would aim to seek reimbursement for those patients with the highest BMI, have co-morbidities, and …
Novo Nordisk to address social inequality in dialogue with healthcare systems -CEO Read More »










